Identification and Characterization of Novel CFTR Potentiators

about

Identification and Characterization of Novel CFTR Potentiators

Item

http://www.wikidata.org/entity/Q58707750

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Identification and Characterization of Novel CFTR Potentiators

@en

Identification and Characterization of Novel CFTR Potentiators

@nl

type

Item

label

Identification and Characterization of Novel CFTR Potentiators

@en

Identification and Characterization of Novel CFTR Potentiators

@nl

prefLabel

Identification and Characterization of Novel CFTR Potentiators

@en

Identification and Characterization of Novel CFTR Potentiators

@nl

P1476

Identification and Characterization of Novel CFTR Potentiators

@en

P2093

Andrew M Swensen

http://www.w3.org/2001/XMLSchema#string

Ann Vandevelde

http://www.w3.org/2001/XMLSchema#string

Anne-Sophie Wesse

http://www.w3.org/2001/XMLSchema#string

Jan Van der Schueren

http://www.w3.org/2001/XMLSchema#string

Kathleen Sonck

http://www.w3.org/2001/XMLSchema#string

Katja Conrath

http://www.w3.org/2001/XMLSchema#string

Katleen Verdonck

http://www.w3.org/2001/XMLSchema#string

Luc Nelles

http://www.w3.org/2001/XMLSchema#string

Maarten Gees

http://www.w3.org/2001/XMLSchema#string

Martin Andrews

http://www.w3.org/2001/XMLSchema#string

P2860

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

Potentiation of ΔF508- and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines

Rapid kinetic analysis of multichannel records by a simultaneous fit to all dwell-time histograms

Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.

Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.

Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.

Potentiators of Defective ΔF508-CFTR Gating that Do Not Interfere with Corrector Action.

Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia.

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

P304

1221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01221

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416447

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6212544

http://www.w3.org/2001/XMLSchema#string